Jonathan is an experienced scientist with end-to-end expertise in bioprocess development, from cell line and strain development through to final formulation and technology transfer for clinical manufacturing. At CPI Biologics, he works across a diverse range of therapeutic modalities - including recombinant proteins, live biotherapeutics, phage-based products, and vaccines - designing bespoke processes tailored to the specific needs of each modality and its intended application within both the UK market and the global landscape.